Publication Information

{'id': 'https://openalex.org/W4301150362', 'doi': 'https://doi.org/10.1136/annrheumdis-2022-eular.1016', 'title': 'POS0239 RISK OF VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS AGED ≥50 YEARS WITH ≥1 CARDIOVASCULAR RISK FACTOR: RESULTS FROM A PHASE 3b/4 RANDOMISED STUDY OF TOFACITINIB VS TUMOUR NECROSIS FACTOR INHIBITORS', 'display_name': 'POS0239 RISK OF VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS AGED ≥50 YEARS WITH ≥1 CARDIOVASCULAR RISK FACTOR: RESULTS FROM A PHASE 3b/4 RANDOMISED STUDY OF TOFACITINIB VS TUMOUR NECROSIS FACTOR INHIBITORS', 'publication_year': 2022, 'publication_date': '2022-05-23', 'ids': {'openalex': 'https://openalex.org/W4301150362', 'doi': 'https://doi.org/10.1136/annrheumdis-2022-eular.1016'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2022-eular.1016', 'pdf_url': 'https://ard.bmj.com/content/annrheumdis/81/Suppl_1/358.full.pdf', 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://ard.bmj.com/content/annrheumdis/81/Suppl_1/358.full.pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5027269428', 'display_name': 'Christina Charles‐Schoeman', 'orcid': 'https://orcid.org/0000-0002-1768-7019'}, 'institutions': [{'id': 'https://openalex.org/I161318765', 'display_name': 'University of California, Los Angeles', 'ror': 'https://ror.org/046rm7j60', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I161318765']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'C. Charles-Schoeman', 'raw_affiliation_strings': ['University of California, Department of Medicine, Los Angeles, CA, United States of America'], 'affiliations': [{'raw_affiliation_string': 'University of California, Department of Medicine, Los Angeles, CA, United States of America', 'institution_ids': ['https://openalex.org/I161318765']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5046261111', 'display_name': 'Roy Fleischmann', 'orcid': 'https://orcid.org/0000-0002-6630-1477'}, 'institutions': [{'id': 'https://openalex.org/I867280407', 'display_name': 'The University of Texas Southwestern Medical Center', 'ror': 'https://ror.org/05byvp690', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I867280407']}, {'id': 'https://openalex.org/I4210096290', 'display_name': 'Metroplex Clinical Research Center', 'ror': 'https://ror.org/00y21a678', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210096290']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'R. M. Fleischmann', 'raw_affiliation_strings': ['Metroplex Clinical Research Center', 'University of Texas Southwestern Medical Center, Department of Internal Medicine, Dallas, TX, United States of America'], 'affiliations': [{'raw_affiliation_string': 'University of Texas Southwestern Medical Center, Department of Internal Medicine, Dallas, TX, United States of America', 'institution_ids': ['https://openalex.org/I867280407']}, {'raw_affiliation_string': 'Metroplex Clinical Research Center', 'institution_ids': ['https://openalex.org/I4210096290']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5021617226', 'display_name': 'E. Mysler', 'orcid': None}, 'institutions': [], 'countries': ['AR'], 'is_corresponding': False, 'raw_author_name': 'E. Mysler', 'raw_affiliation_strings': ['Organización Médica de Investigación, Rheumatology, Buenos Aires, Argentina'], 'affiliations': [{'raw_affiliation_string': 'Organización Médica de Investigación, Rheumatology, Buenos Aires, Argentina', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5024439692', 'display_name': 'M. Greenwald', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210090917', 'display_name': 'Desert Medical Imaging', 'ror': 'https://ror.org/00fjyk033', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210090917']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'M. Greenwald', 'raw_affiliation_strings': ['Desert Medical Advances, Rheumatology, Palm Desert, CA, United States of America'], 'affiliations': [{'raw_affiliation_string': 'Desert Medical Advances, Rheumatology, Palm Desert, CA, United States of America', 'institution_ids': ['https://openalex.org/I4210090917']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5056191186', 'display_name': 'C. Wang', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I180857899', 'display_name': 'Pfizer (United States)', 'ror': 'https://ror.org/01xdqrp08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I180857899']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'C. Wang', 'raw_affiliation_strings': ['Pfizer Inc, Inflammation and Immunology, Groton, CT, United States of America'], 'affiliations': [{'raw_affiliation_string': 'Pfizer Inc, Inflammation and Immunology, Groton, CT, United States of America', 'institution_ids': ['https://openalex.org/I180857899']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5053847020', 'display_name': 'A. S. Chen', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I180857899', 'display_name': 'Pfizer (United States)', 'ror': 'https://ror.org/01xdqrp08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I180857899']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'A. S. Chen', 'raw_affiliation_strings': ['Pfizer Inc, Inflammation and Immunology, Groton, CT, United States of America'], 'affiliations': [{'raw_affiliation_string': 'Pfizer Inc, Inflammation and Immunology, Groton, CT, United States of America', 'institution_ids': ['https://openalex.org/I180857899']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5054463307', 'display_name': 'C. A. Connell', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I180857899', 'display_name': 'Pfizer (United States)', 'ror': 'https://ror.org/01xdqrp08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I180857899']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'C. A. Connell', 'raw_affiliation_strings': ['Pfizer Inc, Inflammation and Immunology, Groton, CT, United States of America'], 'affiliations': [{'raw_affiliation_string': 'Pfizer Inc, Inflammation and Immunology, Groton, CT, United States of America', 'institution_ids': ['https://openalex.org/I180857899']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058435837', 'display_name': 'J. Woolcott', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I180857899', 'display_name': 'Pfizer (United States)', 'ror': 'https://ror.org/01xdqrp08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I180857899']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'J. Woolcott', 'raw_affiliation_strings': ['Pfizer Inc, Inflammation and Immunology, Collegeville, PA, United States of America'], 'affiliations': [{'raw_affiliation_string': 'Pfizer Inc, Inflammation and Immunology, Collegeville, PA, United States of America', 'institution_ids': ['https://openalex.org/I180857899']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5025582592', 'display_name': 'S. Menon', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I180857899', 'display_name': 'Pfizer (United States)', 'ror': 'https://ror.org/01xdqrp08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I180857899']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'S. Menon', 'raw_affiliation_strings': ['Pfizer Inc, Inflammation and Immunology, Groton, CT, United States of America'], 'affiliations': [{'raw_affiliation_string': 'Pfizer Inc, Inflammation and Immunology, Groton, CT, United States of America', 'institution_ids': ['https://openalex.org/I180857899']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5050094194', 'display_name': 'Y. Chen', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I180857899', 'display_name': 'Pfizer (United States)', 'ror': 'https://ror.org/01xdqrp08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I180857899']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Y. Chen', 'raw_affiliation_strings': ['Pfizer Inc, Inflammation and Immunology, New York, NY, United States of America'], 'affiliations': [{'raw_affiliation_string': 'Pfizer Inc, Inflammation and Immunology, New York, NY, United States of America', 'institution_ids': ['https://openalex.org/I180857899']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039423200', 'display_name': 'K. Lee', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I180857899', 'display_name': 'Pfizer (United States)', 'ror': 'https://ror.org/01xdqrp08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I180857899']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'K. Lee', 'raw_affiliation_strings': ['Pfizer Inc, Inflammation and Immunology, New York, NY, United States of America'], 'affiliations': [{'raw_affiliation_string': 'Pfizer Inc, Inflammation and Immunology, New York, NY, United States of America', 'institution_ids': ['https://openalex.org/I180857899']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5062360885', 'display_name': 'Z. Szekanecz', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I132735039', 'display_name': 'University of Debrecen', 'ror': 'https://ror.org/02xf66n48', 'country_code': 'HU', 'type': 'education', 'lineage': ['https://openalex.org/I132735039']}], 'countries': ['HU'], 'is_corresponding': False, 'raw_author_name': 'Z. Szekanecz', 'raw_affiliation_strings': ['University of Debrecen, Division of Rheumatology, Faculty of Medicine, Debrecen, Hungary'], 'affiliations': [{'raw_affiliation_string': 'University of Debrecen, Division of Rheumatology, Faculty of Medicine, Debrecen, Hungary', 'institution_ids': ['https://openalex.org/I132735039']}]}], 'institution_assertions': [], 'countries_distinct_count': 3, 'institutions_distinct_count': 6, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 5.493, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 14, 'citation_normalized_percentile': {'value': 0.999441, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 94, 'max': 95}, 'biblio': {'volume': '81', 'issue': 'Suppl 1', 'first_page': '358', 'last_page': '359'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10285', 'display_name': 'Venous Thromboembolism Diagnosis and Management', 'score': 0.9921, 'subfield': {'id': 'https://openalex.org/subfields/2724', 'display_name': 'Internal Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10285', 'display_name': 'Venous Thromboembolism Diagnosis and Management', 'score': 0.9921, 'subfield': {'id': 'https://openalex.org/subfields/2724', 'display_name': 'Internal Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9876, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9856, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9769816}, {'id': 'https://openalex.org/C2778886723', 'wikidata': 'https://www.wikidata.org/wiki/Q3530324', 'display_name': 'Tofacitinib', 'level': 3, 'score': 0.9109001}, {'id': 'https://openalex.org/C2777575956', 'wikidata': 'https://www.wikidata.org/wiki/Q187255', 'display_name': 'Rheumatoid arthritis', 'level': 2, 'score': 0.7197726}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.6652148}, {'id': 'https://openalex.org/C2777226972', 'wikidata': 'https://www.wikidata.org/wiki/Q415343', 'display_name': 'Etanercept', 'level': 3, 'score': 0.58446574}, {'id': 'https://openalex.org/C207103383', 'wikidata': 'https://www.wikidata.org/wiki/Q3930246', 'display_name': 'Hazard ratio', 'level': 3, 'score': 0.49528947}, {'id': 'https://openalex.org/C141071460', 'wikidata': 'https://www.wikidata.org/wiki/Q40821', 'display_name': 'Surgery', 'level': 1, 'score': 0.40149575}, {'id': 'https://openalex.org/C44249647', 'wikidata': 'https://www.wikidata.org/wiki/Q208498', 'display_name': 'Confidence interval', 'level': 2, 'score': 0.24469233}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2022-eular.1016', 'pdf_url': 'https://ard.bmj.com/content/annrheumdis/81/Suppl_1/358.full.pdf', 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2022-eular.1016', 'pdf_url': 'https://ard.bmj.com/content/annrheumdis/81/Suppl_1/358.full.pdf', 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.74, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4205635507', 'https://openalex.org/W3035443521', 'https://openalex.org/W3015942815', 'https://openalex.org/W3001590743', 'https://openalex.org/W2929695502', 'https://openalex.org/W2906724980', 'https://openalex.org/W2899812541', 'https://openalex.org/W2503659988', 'https://openalex.org/W2315545909', 'https://openalex.org/W2058435704'], 'abstract_inverted_index': {'Background': [0], 'ORAL': [1, 78, 622], 'Surveillance': [2], '(': [3], 'NCT02092467': [4], ')': [5], 'was': [6, 182, 475, 603, 678], 'a': [7, 46, 95, 183, 275, 413, 471, 566, 577, 588], 'randomised,': [8], 'open-label,': [9], 'non-inferiority,': [10], 'Phase': [11], '3b/4': [12], 'study': [13, 194], 'assessing': [14], 'the': [15, 490], 'relative': [16], 'risk': [17, 48, 57, 62, 176, 344, 391, 530, 551, 580, 592, 596, 658], 'of': [18, 49, 63, 138, 188, 271, 278, 284, 352, 377, 405, 465, 478, 482, 526, 569, 591, 651, 691], 'major': [19], 'adverse': [20], 'cardiovascular': [21], '(CV)': [22], 'events': [23, 66], '(MACE)': [24], 'and': [25, 45, 73, 118, 127, 133, 144, 205, 216, 228, 240, 260, 292, 301, 307, 312, 314, 324, 330, 335, 337, 375, 484, 517, 547, 576, 608, 626, 644, 685, 702, 710, 733, 766, 781, 790, 804, 889, 902, 913], 'malignancies': [26], 'with': [27, 36, 113, 234, 241, 267, 647], 'tofacitinib': [28, 86, 151, 209, 236, 242, 290, 514, 633], 'vs': [29, 157, 238, 244, 268, 297, 639, 648], 'TNF': [30], 'inhibitors': [31], '(TNFi)': [32], 'in': [33, 77, 265, 492, 582, 600, 621], 'patients': [34], '(pts)': [35], 'moderate': [37], 'to': [38, 148, 170, 223, 386, 544, 561, 598], 'severe': [39], 'rheumatoid': [40], 'arthritis': [41], 'despite': [42], 'methotrexate': [43], '(MTX)': [44], 'high': [47], 'MACE': [50], '(aged': [51], '≥50': [52], 'yrs;': [53], '≥1': [54], 'additional': [55], 'CV': [56], 'factor).': [58], 'Objectives': [59], 'To': [60], 'assess': [61], 'venous': [64], 'thromboembolic': [65], '(VTE;': [67], 'including': [68], 'deep': [69], 'vein': [70], 'thrombosis': [71], '[DVT]': [72], 'pulmonary': [74], 'embolism': [75], '[PE])': [76], 'Surveillance.': [79], 'Methods': [80], 'Pts': [81], 'on': [82, 528, 613], 'stable': [83], 'MTX': [84], 'received': [85], '5': [87, 152, 210, 245, 291, 321, 636], 'or': [88, 94, 101, 153, 192], '10': [89, 154, 213, 243, 293], 'mg': [90, 99, 104, 155, 211, 214, 246, 294, 637], 'twice': [91], 'daily': [92], '(BID)': [93], 'TNFi': [96, 298, 640], '(etanercept': [97], '50': [98], 'weekly': [100], 'adalimumab': [102], '40': [103, 325], 'once': [105], 'every': [106], '2': [107, 361, 423], 'weeks).': [108], 'Incidence': [109], 'rates': [110], '(IRs;': [111], 'pts': [112, 135, 207, 266, 279, 326, 332, 339, 646], 'first': [114], 'events/100': [115], 'pt-yrs': [116], '[PY])': [117], '95%': [119], 'CIs': [120], 'were': [121, 159, 166, 231, 249, 263, 299, 510, 629], 'calculated': [122, 160], 'for': [123, 134, 178, 289, 304, 310, 317, 327, 333, 340, 346, 393, 494, 500, 506, 595, 632, 645, 660], 'adjudicated': [124], 'VTE,': [125, 142, 226, 258, 305, 328, 353, 624], 'DVT': [126, 143, 227, 259, 625], 'PE': [128, 229, 261, 347, 394, 529, 555, 627, 661], '(overall': [129], 'by': [130, 672, 680, 687], '6-month': [131, 221, 642], 'interval': [132], 'with/without': [136], 'history': [137, 270, 283, 351, 376, 650], 'VTE).': [139], 'For': [140], 'overall': [141, 172, 388, 548], 'PE,': [145, 318], 'numbers': [146], 'needed': [147], 'harm': [149], '(NNH;': [150], 'BID': [156, 215], 'TNFi)': [158], 'post': [161, 168], 'hoc.': [162], 'Multivariate': [163, 383, 533, 653], 'Cox': [164, 384, 534, 570, 654], 'models': [165, 655], 'used': [167], 'hoc': [169], 'identify': [171, 387, 489], 'independent': [173, 389, 550], 'baseline': [174], '(BL)': [175], 'factors': [177, 345, 392, 552, 659], 'PE.': [179, 341], 'Censoring': [180], 'time': [181, 252], '28-day': [184], 'on-treatment': [185], 'period': [186], '(minimum': [187], 'last': [189, 193], 'contact': [190], 'date': [191, 197], 'treatment': [195, 281, 540, 575, 667], 'dose': [196], '+28': [198], 'days).': [199], 'Results': [200], 'Analysis': [201], 'included': [202, 350, 539, 574], '1455,': [203], '1456': [204], '1451': [206], 'receiving': [208], 'BID,': [212, 295], 'TNFi,': [217, 239], 'respectively.': [218], 'Generally,': [219, 620], 'across': [220, 251, 348, 395, 496, 558, 641], 'intervals': [222], '>54': [224], 'months,': [225], 'IRs': [230, 248, 262, 556, 628], 'numerically': [232, 630], 'higher': [233, 264, 631], 'both': [235], 'doses': [237, 515], 'BID;': [247], 'consistent': [250], '(data': [253], 'not': [254, 488], 'shown).': [255], 'Across': [256], 'treatments,': [257], 'without': [269, 649], 'VTE;': [272], 'however,': [273], 'only': [274], 'small': [276], 'number': [277], 'per': [280], 'had': [282], 'VTE': [285, 406], '(Figure': [286], '1).': [287, 380], 'NNH': [288], 'respectively,': [296], '763': [300], '198': [302], 'PY': [303, 309, 316], '1347': [306], '589': [308], 'DVT,': [311, 334], '870': [313], '229': [315], 'or,': [319], 'over': [320], 'yrs,': [322, 369], '153': [323], '269': [329], '118': [331], '174': [336], '46': [338], 'Identified': [342], 'BL': [343, 390, 402, 472, 502, 507, 521, 657], 'treatments': [349, 396, 497], 'antidepressant': [354, 473], 'use,': [355, 364, 374], 'body': [356], 'mass': [357, 419], 'index': [358, 420], '≥30': [359, 421], 'kg/m': [360, 422], ',': [362], 'corticosteroid': [363, 508, 522], 'male': [365], 'sex,': [366], 'age': [367], '≥65': [368, 451], 'oral': [370], 'contraceptives/hormone-replacement': [371], 'therapy': [372], '(HRT)': [373], 'hypertension': [378, 466], '(Table': [379], 'Table': [381], '1.': [382], 'analyses': [385, 572], 'HR': [397, 609], '(95%': [398, 610], 'CI)': [399, 611], 'p': [400, 606], 'value': [401, 607], 'covariate': [403], 'History': [404, 464], '7.06': [407], '(2.46,': [408], '20.25)': [409], '0.0003': [410], 'Antidepressant': [411], 'use': [412, 429, 438, 459, 474, 509, 523], '2.94': [414], '(1.44,': [415], '6.02)': [416], '0.0032': [417], 'Body': [418], '2.97': [424], '(1.40,': [425, 432], '6.32)': [426], '0.0047': [427, 434], 'Corticosteroid': [428], 'b': [430, 498], '3.01': [431], '6.46)': [433], 'Proton': [435], 'pump': [436], 'inhibitor': [437], '0.32': [439], '(0.15,': [440], '0.71)': [441], '0.0052': [442], 'Male': [443], 'sex': [444, 527], 'c': [445, 524], '2.18': [446], '(1.06,': [447], '4.48)': [448], '0.0340': [449], 'Age': [450], 'yrs': [452], '2.00': [453], '(1.03,': [454], '3.88)': [455], '0.0401': [456], 'Oral': [457], 'contraceptives/HRT': [458], '3.56': [460], '(1.05,': [461], '12.10)': [462], '0.0422': [463], '2.57': [467], '(0.98,': [468], '6.76)': [469], '0.0554': [470], 'an': [476, 479], 'indicator': [477], 'underlying': [480], 'condition': [481], 'depression,': [483], 'subgroup': [485], 'analysis': [486], 'did': [487], 'difference': [491], 'HRs': [493, 505], 'depression': [495], 'Proxy': [499], 'elevated': [501], 'disease': [503], 'activity;': [504], 'similar': [511], 'between': [512], 'all': [513], 'combined': [516], 'TNFi;': [518], 'includes': [519], 'any': [520], 'Impact': [525], 'considered': [531], 'inconclusive': [532], 'model': [535, 545, 562, 584, 602, 615], 'using': [536], 'backward': [537], 'selection': [538], 'effects': [541], '(not': [542], 'subject': [543, 560], 'selection)': [546, 563], 'potential': [549], '(those': [553], 'affecting': [554], 'equally': [557], 'treatments;': [559], 'identified': [564, 656], 'from': [565], 'prior': [567], 'set': [568, 590], 'regression': [571], '(which': [573], 'single': [578], 'candidate': [579], 'factor': [581, 597], 'each': [583], 'fitting,': [585], 'cycling': [586], 'through': [587], 'predetermined': [589], 'factors);': [593], 'cut-off': [594], 'stay': [599], 'multivariate': [601], 'p<0.10;': [604], 'nominal': [605], 'based': [612], 'this': [614], 'HR,': [616], 'hazard': [617], 'ratio': [618], 'Conclusion': [619], 'Surveillance,': [623], '(10': [634], '>': [635], 'BID)': [638], 'intervals,': [643], 'VTE.': [652], 'that': [662], 'may': [663], 'help': [664], 'support': [665, 677, 705, 736, 784, 795, 916], 'future': [666], 'decisions.': [668], 'Acknowledgements': [669], 'Study': [670], 'sponsored': [671], 'Pfizer': [673, 688, 700, 711, 730, 756, 778, 788, 805, 811, 815, 821, 825, 832, 836, 842, 846, 852, 856, 862, 866, 872, 876, 886, 900, 910, 918], 'Inc.': [674, 689], 'Medical': [675], 'writing': [676], 'provided': [679], 'Emma': [681], 'Mitchell,': [682], 'CMC': [683], 'Connect,': [684], 'funded': [686], 'Disclosure': [690], 'Interests': [692], 'Christina': [693], 'Charles-Schoeman': [694], 'Consultant': [695, 716, 904], 'of:': [696, 717, 810, 814, 820, 824, 831, 835, 841, 845, 851, 855, 861, 865, 871, 875, 905], 'AbbVie,': [697, 707, 718, 738, 772, 797, 882, 894, 906], 'Gilead': [698, 725, 749, 801], 'Sciences,': [699, 726, 750, 802], 'Inc': [701, 789, 901, 919], 'Regeneron-Sanofi,': [703], 'Grant/research': [704, 735, 783, 794, 915], 'from:': [706, 737, 785, 796, 917], 'Bristol-Myers': [708, 720, 741, 773], 'Squibb': [709], 'Inc,': [712, 731, 757, 779, 806, 812, 816, 822, 826, 833, 837, 843, 847, 853, 857, 863, 867, 873, 877, 887, 911], 'Roy': [713], 'M.': [714], 'Fleischmann': [715], 'Amgen,': [719, 739], 'Squibb,': [721, 742, 774], 'Eli': [722, 743, 775, 786, 798, 883, 895, 907], 'Lilly,': [723, 744, 776, 787, 799, 884, 896, 908], 'Galvani,': [724, 747], 'GSK,': [727, 751], 'Janssen,': [728, 753, 777], 'Novartis,': [729, 754, 885, 899, 909], 'Sanofi-Aventis': [732], 'UCB,': [734, 764], 'AstraZeneca,': [740], 'Flexion,': [745], 'Galapagos,': [746, 800], 'Genentech,': [748], 'Horizon,': [752], 'Noven,': [755], 'Samumed,': [758], 'Sanofi': [759], 'Aventis,': [760], 'SciSelecta,': [761], 'Teva': [762], 'Pharmaceuticals,': [763], 'Viela': [765], 'Vorso,': [767], 'Eduardo': [768], 'Mysler': [769], 'Speakers': [770, 880], 'bureau:': [771, 881], 'Roche': [780, 888, 912], 'Sanofi,': [782, 890, 914], 'Roche,': [791, 903], 'Maria': [792], 'Greenwald': [793], 'Novartis': [803], 'Cunshan': [807], 'Wang': [808], 'Shareholder': [809, 819, 830, 840, 850, 860, 870], 'Employee': [813, 823, 834, 844, 854, 864, 874], 'All-shine': [817], 'Chen': [818, 859], 'Carol': [827], 'A.': [828], 'Connell': [829], 'John': [838], 'Woolcott': [839], 'Sujatha': [848], 'Menon': [849], 'Yan': [858], 'Kristen': [868], 'Lee': [869], 'Zoltán': [878], 'Szekanecz': [879], 'Paid': [891], 'instructor': [892], 'for:': [893], 'Gedeon': [897], 'Richter,': [898]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4301150362', 'counts_by_year': [{'year': 2024, 'cited_by_count': 3}, {'year': 2023, 'cited_by_count': 5}, {'year': 2022, 'cited_by_count': 6}], 'updated_date': '2024-12-12T17:24:21.492997', 'created_date': '2022-10-04'}